BPA for bylvay
Active Awarded Last action
- Contract number
- 36E79722A0015
- Awardee
-
Albireo Pharma, Inc. UEI GQGYRLY83ZA1
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 91% complete
- IDV ceiling
- $883,061.15
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Albireo Pharma, Inc. was awarded a single-award Blanket Purchase Agreement (BPA) valued at $883,061.15 by the Department of Veterans Affairs (VA) National Acquisition Center for the supply of Bylvay, a pharmaceutical treatment for progressive familial intrahepatic cholestasis, a rare liver disease. The BPA was established on April 1, 2022, under the Pharmaceuticals and Drugs General Services Administration Federal Supply Schedule (FSS-61-IB) and represents Exercise Option Year 4 of BPA 36E79722A0015. This indefinite delivery vehicle does not utilize any set-aside provisions and facilitates the delivery of Bylvay through task orders to VA medical centers nationwide. The contract has an ultimate completion date of March 31, 2027, providing a structured procurement mechanism for the VA to obtain this specialized pharmaceutical on an as-needed basis throughout the performance period.
The BPA enables the VA to procure Bylvay without individual competitive solicitations for each requirement, streamlining the acquisition process for this critical therapeutic agent supporting veteran healthcare. By establishing a blanket purchase agreement with a single vendor on the GSA Schedule, the VA achieves pricing efficiency and supply chain stability for a specialized pharmaceutical with limited commercial availability. The vehicle's structure allows for flexible ordering quantities and delivery schedules aligned with VA medical center demand, while maintaining ceiling value protections. This procurement approach is consistent with VA's strategy to ensure continuous access to rare disease treatments for the veteran population while optimizing procurement administrative burden and cost management.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79722A0015?
36E79722A0015 was awarded to Albireo Pharma, Inc. by National Acquisition Center (Headquarters) on April 1, 2022.
How much is contract 36E79722A0015 worth?
36E79722A0015's own ceiling is $883,061.
Who can order from contract 36E79722A0015?
36E79722A0015 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79722A0015 under another contract?
Yes. 36E79722A0015 is a blanket purchase agreement under 36F79722D0094, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79722A0015 competed?
The extent of competition for 36E79722A0015 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV